BIOMAT Database Logo BIOMAT Database Logo

[A case of familial hypercholesterolemia associated with Basedow's disease]. 1987

S Nakao, and M Ueda, and S Yamashita, and Y Matsuzawa, and M Harada, and T Matsuda

UI MeSH Term Description Entries
D008297 Male Males
D011341 Probucol A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993). Biphenabid,DH-581,Lorelco,Lurselle,Panavir,Superlipid,DH 581,DH581
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006938 Hyperlipoproteinemia Type II A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). Hyperbetalipoproteinemia,Hypercholesterolemia, Essential,Hypercholesterolemia, Familial,Apolipoprotein B-100, Familial Defective,Apolipoprotein B-100, Familial Ligand-Defective,Familial Combined Hyperlipoproteinemia,Hyper-Low Density Lipoproteinemia,Hyper-Low-Density-Lipoproteinemia,Hyper-beta-Lipoproteinemia,Hypercholesterolemia, Autosomal Dominant,Hypercholesterolemia, Autosomal Dominant, Type B,Hypercholesterolemic Xanthomatosis, Familial,Hyperlipoproteinemia Type 2,Hyperlipoproteinemia Type IIa,Hyperlipoproteinemia Type IIb,Hyperlipoproteinemia, Type II,Hyperlipoproteinemia, Type IIa,LDL Receptor Disorder,Apolipoprotein B 100, Familial Defective,Apolipoprotein B 100, Familial Ligand Defective,Autosomal Dominant Hypercholesterolemia,Autosomal Dominant Hypercholesterolemias,Combined Hyperlipoproteinemia, Familial,Combined Hyperlipoproteinemias, Familial,Density Lipoproteinemia, Hyper-Low,Density Lipoproteinemias, Hyper-Low,Disorder, LDL Receptor,Disorders, LDL Receptor,Dominant Hypercholesterolemia, Autosomal,Dominant Hypercholesterolemias, Autosomal,Essential Hypercholesterolemia,Essential Hypercholesterolemias,Familial Combined Hyperlipoproteinemias,Familial Hypercholesterolemia,Familial Hypercholesterolemias,Familial Hypercholesterolemic Xanthomatoses,Familial Hypercholesterolemic Xanthomatosis,Hyper Low Density Lipoproteinemia,Hyper beta Lipoproteinemia,Hyper-Low Density Lipoproteinemias,Hyper-Low-Density-Lipoproteinemias,Hyper-beta-Lipoproteinemias,Hyperbetalipoproteinemias,Hypercholesterolemias, Autosomal Dominant,Hypercholesterolemias, Essential,Hypercholesterolemias, Familial,Hypercholesterolemic Xanthomatoses, Familial,Hyperlipoproteinemia Type 2s,Hyperlipoproteinemia Type IIas,Hyperlipoproteinemia Type IIbs,Hyperlipoproteinemia Type IIs,Hyperlipoproteinemia, Familial Combined,Hyperlipoproteinemias, Familial Combined,Hyperlipoproteinemias, Type II,Hyperlipoproteinemias, Type IIa,LDL Receptor Disorders,Lipoproteinemia, Hyper-Low Density,Lipoproteinemias, Hyper-Low Density,Receptor Disorder, LDL,Receptor Disorders, LDL,Type 2, Hyperlipoproteinemia,Type II Hyperlipoproteinemia,Type II Hyperlipoproteinemias,Type IIa Hyperlipoproteinemia,Type IIa Hyperlipoproteinemias,Xanthomatoses, Familial Hypercholesterolemic,Xanthomatosis, Familial Hypercholesterolemic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013974 Thyroxine The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. L-Thyroxine,Levothyroxine,T4 Thyroid Hormone,3,5,3',5'-Tetraiodothyronine,Berlthyrox,Dexnon,Eferox,Eltroxin,Eltroxine,Euthyrox,Eutirox,L-3,5,3',5'-Tetraiodothyronine,L-Thyrox,L-Thyroxin Henning,L-Thyroxin beta,L-Thyroxine Roche,Levo-T,Levothroid,Levothyroid,Levothyroxin Deladande,Levothyroxin Delalande,Levothyroxine Sodium,Levoxine,Levoxyl,Lévothyrox,Novothyral,Novothyrox,O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine,O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine,Oroxine,Sodium Levothyroxine,Synthroid,Synthrox,Thevier,Thyrax,Thyroxin,Tiroidine,Tiroxina Leo,Unithroid,L Thyrox,L Thyroxin Henning,L Thyroxin beta,L Thyroxine,L Thyroxine Roche,Levo T,Thyroid Hormone, T4
D014284 Triiodothyronine A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3. Liothyronine,T3 Thyroid Hormone,3,3',5-Triiodothyronine,Cytomel,Liothyronine Sodium,Thyroid Hormone, T3

Related Publications

S Nakao, and M Ueda, and S Yamashita, and Y Matsuzawa, and M Harada, and T Matsuda
[A case of familial hypercholesterolemia associated with nephrotic syndrome].
August 1990, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
S Nakao, and M Ueda, and S Yamashita, and Y Matsuzawa, and M Harada, and T Matsuda
[A case of familial hypercholesterolemia associated with Schnyder's corneal dystrophy].
July 1988, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
S Nakao, and M Ueda, and S Yamashita, and Y Matsuzawa, and M Harada, and T Matsuda
[Case of acute hepatitis associated with Basedow's disease].
January 2007, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
S Nakao, and M Ueda, and S Yamashita, and Y Matsuzawa, and M Harada, and T Matsuda
[Familial occurrence of Basedow's disease].
July 1973, Nihon Naibunpi Gakkai zasshi,
S Nakao, and M Ueda, and S Yamashita, and Y Matsuzawa, and M Harada, and T Matsuda
[A case of fasciitis associated with Basedow's disease and polymyositis].
January 1998, Rinsho shinkeigaku = Clinical neurology,
S Nakao, and M Ueda, and S Yamashita, and Y Matsuzawa, and M Harada, and T Matsuda
[A case of chronic progressive external ophthalmoplegia associated with familial hypercholesterolemia].
January 1992, Rinsho shinkeigaku = Clinical neurology,
S Nakao, and M Ueda, and S Yamashita, and Y Matsuzawa, and M Harada, and T Matsuda
[A case of pseudoxanthoma elasticum associated with familial hypercholesterolemia (author's transl)].
March 1981, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
S Nakao, and M Ueda, and S Yamashita, and Y Matsuzawa, and M Harada, and T Matsuda
[A further case of juvenile coronary disease with xanthomatous familial hypercholesterolemia].
January 1965, Revue de l'atherosclerose,
S Nakao, and M Ueda, and S Yamashita, and Y Matsuzawa, and M Harada, and T Matsuda
[Case of diabetes mellitus associated with hypothyroidism and familial hypercholesterolemia].
May 1983, Horumon to rinsho. Clinical endocrinology,
S Nakao, and M Ueda, and S Yamashita, and Y Matsuzawa, and M Harada, and T Matsuda
Familial hypercholesterolemia with early coronary atherosclerotic heart disease: A case report.
August 2019, Experimental and therapeutic medicine,
Copied contents to your clipboard!